Old Web
English
Sign In
Acemap
>
authorDetail
>
Brian R. Creese
Brian R. Creese
Medicine
Heparanase
Internal medicine
Vascular endothelial growth factor
Toxicity
7
Papers
233
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies
2008
Cancer Chemotherapy and Pharmacology
Laura Q. Chow
Daniel L. Gustafson
Cindy L. O’Bryant
Lia Gore
Michele Basche
Scott N. Holden
Mark Morrow
Stacy Grolnic
Brian R. Creese
Kaye L. Roberts
Kat Davis
R. S. Addison
S. Gail Eckhardt
Show All
Source
Cite
Save
Citations (19)
A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors
2006
Clinical Cancer Research
Michele Basche
Daniel L. Gustafson
Scott N. Holden
Cindy L. O'Bryant
Lia Gore
Samir E. Witta
Mary Kay Schultz
Mark Morrow
Adrah Levin
Brian R. Creese
Michael Kangas
Kaye L. Roberts
Thu Suong T. Nguyen
Kat Davis
R. S. Addison
Jane C. Moore
S. Gail Eckhardt
Show All
Source
Cite
Save
Citations (88)
A phase II trial of PI-88, a novel antiangiogenic and antimetastatic heparanase inhibitor, in patients with advanced melanoma
2005
Journal of Clinical Oncology
D. Thomson
Rene Gonzalez
Michael Millward
Timothy Jay Price
Andrew Haydon
William A. Robinson
Alex Powell
Kaye L. Roberts
Brian R. Creese
Show All
Source
Cite
Save
Citations (2)
A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis
2004
Journal of The American Society of Nephrology
Vicki Levidiotis
Craig Freeman
Malcolm Punler
Paul Martinello
Brian R. Creese
Vito Ferro
Johan van der Vlag
J.H.M. Berden
Christopher R. Parish
David A. Power
Show All
Source
Cite
Save
Citations (52)
1